487 related articles for article (PubMed ID: 1311774)
21. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.
Hazen-Martin DJ; Re GG; Garvin AJ; Sens DA
Am J Pathol; 1994 May; 144(5):1023-34. PubMed ID: 8178926
[TBL] [Abstract][Full Text] [Related]
22. Two molecular subgroups of Wilms' tumors with or without WT1 mutations.
Schumacher V; Schuhen S; Sonner S; Weirich A; Leuschner I; Harms D; Licht J; Roberts S; Royer-Pokora B
Clin Cancer Res; 2003 Jun; 9(6):2005-14. PubMed ID: 12796362
[TBL] [Abstract][Full Text] [Related]
23. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.
Natrajan R; Reis-Filho JS; Little SE; Messahel B; Brundler MA; Dome JS; Grundy PE; Vujanic GM; Pritchard-Jones K; Jones C
Cancer Res; 2006 Dec; 66(23):11148-55. PubMed ID: 17145858
[TBL] [Abstract][Full Text] [Related]
24. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
Hewitt SM; Saunders GF
Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
[TBL] [Abstract][Full Text] [Related]
25. Eel WT1 sequence and expression in spontaneous nephroblastomas in Japanese eel.
Nakatsuru Y; Minami K; Yoshikawa A; Zhu J; Oda H; Masahito P; Okamoto N; Nakamura Y; Ishikawa T
Gene; 2000 Mar; 245(2):245-51. PubMed ID: 10717475
[TBL] [Abstract][Full Text] [Related]
26. Expression of the Wilms' tumor gene WT1 in the murine urogenital system.
Pelletier J; Schalling M; Buckler AJ; Rogers A; Haber DA; Housman D
Genes Dev; 1991 Aug; 5(8):1345-56. PubMed ID: 1651275
[TBL] [Abstract][Full Text] [Related]
27. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
[TBL] [Abstract][Full Text] [Related]
28. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.
Werner H; Re GG; Drummond IA; Sukhatme VP; Rauscher FJ; Sens DA; Garvin AJ; LeRoith D; Roberts CT
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5828-32. PubMed ID: 8390684
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
31. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
Eccles MR; Yun K; Reeve AE; Fidler AE
Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
[TBL] [Abstract][Full Text] [Related]
32. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
34. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
Simms LA; Algar EM; Smith PJ
Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
36. Nephroblastic neoplasms.
Khoury JD
Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
38. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.
Maschietto M; Trapé AP; Piccoli FS; Ricca TI; Dias AA; Coudry RA; Galante PA; Torres C; Fahhan L; Lourenço S; Grundy PE; de Camargo B; de Souza S; Neves EJ; Soares FA; Brentani H; Carraro DM
Cell Death Dis; 2011 Nov; 2(11):e224. PubMed ID: 22048167
[TBL] [Abstract][Full Text] [Related]
39. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
40. Identification of genetically aberrant cell lineages in Wilms' tumors.
Weremowicz S; Kozakewich HP; Haber D; Park S; Morton CC; Fletcher JA
Genes Chromosomes Cancer; 1994 May; 10(1):40-8. PubMed ID: 7519872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
